Global and United States Cardiac Marker Market Insights, Forecast to 2026

Publisher Name :
Date: 16-Oct-2020
No. of pages: 148
Inquire Before Buying

Cardiac Marker market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Marker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Cardiac Marker market is segmented into

- Creatine kinase (CK) MB

- Troponin (cTnI and cTnT)

- BNP & NT-proBNP

- Myogloblin

- Others (hs-CRP, D-Dimer, etc.)

Segment by Application, the Cardiac Marker market is segmented into

- Myocardial Infarction

- Congestive Heart Failure

- Acute Coronary Syndrome

- Atherosclerosis

- Others

Regional and Country-level Analysis

The Cardiac Marker market is analysed and market size information is provided by regions (countries).

The key regions covered in the Cardiac Marker market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Cardiac Marker Market Share Analysis

Cardiac Marker market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cardiac Marker business, the date to enter into the Cardiac Marker market, Cardiac Marker product introduction, recent developments, etc.

The major vendors covered:

- HyTest

- Abbott

- Roche Diagnostics

- BG Medicine

- Biomerieux

- Critical Diagnostics

- DiaDexus

- Response Biomedical

- Siemens Healthcare

- Singulex

- Thermo Scientific

- Trinity Biotech

- Sunfory

- Lee BioSolutions

Global and United States Cardiac Marker Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Cardiac Marker Product Introduction
1.2 Market Segments
1.3 Key Cardiac Marker Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cardiac Marker Market Size Growth Rate by Type
1.4.2 Creatine kinase (CK) MB
1.4.3 Troponin (cTnI and cTnT)
1.4.4 BNP & NT-proBNP
1.4.5 Myogloblin
1.4.6 Others (hs-CRP, D-Dimer, etc.)
1.5 Market by Application
1.5.1 Global Cardiac Marker Market Size Growth Rate by Application
1.5.2 Myocardial Infarction
1.5.3 Congestive Heart Failure
1.5.4 Acute Coronary Syndrome
1.5.5 Atherosclerosis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cardiac Marker Market Size, Estimates and Forecasts
2.1.1 Global Cardiac Marker Revenue 2015-2026
2.1.2 Global Cardiac Marker Sales 2015-2026
2.2 Global Cardiac Marker, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Cardiac Marker Historical Market Size by Region (2015-2020)
2.3.1 Global Cardiac Marker Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Cardiac Marker Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Cardiac Marker Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Cardiac Marker Sales Forecast by Region (2021-2026)
2.4.2 Global Cardiac Marker Revenue Forecast by Region (2021-2026)
3 Global Cardiac Marker Competitor Landscape by Players
3.1 Global Top Cardiac Marker Sales by Manufacturers
3.1.1 Global Cardiac Marker Sales by Manufacturers (2015-2020)
3.1.2 Global Cardiac Marker Sales Market Share by Manufacturers (2015-2020)
3.2 Global Cardiac Marker Manufacturers by Revenue
3.2.1 Global Cardiac Marker Revenue by Manufacturers (2015-2020)
3.2.2 Global Cardiac Marker Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cardiac Marker Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cardiac Marker Revenue in 2019
3.2.5 Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cardiac Marker Price by Manufacturers
3.4 Global Cardiac Marker Manufacturing Base Distribution, Product Types
3.4.1 Cardiac Marker Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cardiac Marker Product Type
3.4.3 Date of International Manufacturers Enter into Cardiac Marker Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cardiac Marker Market Size by Type (2015-2020)
4.1.1 Global Cardiac Marker Sales by Type (2015-2020)
4.1.2 Global Cardiac Marker Revenue by Type (2015-2020)
4.1.3 Cardiac Marker Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cardiac Marker Market Size Forecast by Type (2021-2026)
4.2.1 Global Cardiac Marker Sales Forecast by Type (2021-2026)
4.2.2 Global Cardiac Marker Revenue Forecast by Type (2021-2026)
4.2.3 Cardiac Marker Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cardiac Marker Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cardiac Marker Market Size by Application (2015-2020)
5.1.1 Global Cardiac Marker Sales by Application (2015-2020)
5.1.2 Global Cardiac Marker Revenue by Application (2015-2020)
5.1.3 Cardiac Marker Price by Application (2015-2020)
5.2 Cardiac Marker Market Size Forecast by Application (2021-2026)
5.2.1 Global Cardiac Marker Sales Forecast by Application (2021-2026)
5.2.2 Global Cardiac Marker Revenue Forecast by Application (2021-2026)
5.2.3 Global Cardiac Marker Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Cardiac Marker Market Size YoY Growth 2015-2026
6.1.1 United States Cardiac Marker Sales YoY Growth 2015-2026
6.1.2 United States Cardiac Marker Revenue YoY Growth 2015-2026
6.1.3 United States Cardiac Marker Market Share in Global Market 2015-2026
6.2 United States Cardiac Marker Market Size by Players (International and Local Players)
6.2.1 United States Top Cardiac Marker Players by Sales (2015-2020)
6.2.2 United States Top Cardiac Marker Players by Revenue (2015-2020)
6.3 United States Cardiac Marker Historic Market Review by Type (2015-2020)
6.3.1 United States Cardiac Marker Sales Market Share by Type (2015-2020)
6.3.2 United States Cardiac Marker Revenue Market Share by Type (2015-2020)
6.3.3 United States Cardiac Marker Price by Type (2015-2020)
6.4 United States Cardiac Marker Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Cardiac Marker Sales Forecast by Type (2021-2026)
6.4.2 United States Cardiac Marker Revenue Forecast by Type (2021-2026)
6.4.3 United States Cardiac Marker Price Forecast by Type (2021-2026)
6.5 United States Cardiac Marker Historic Market Review by Application (2015-2020)
6.5.1 United States Cardiac Marker Sales Market Share by Application (2015-2020)
6.5.2 United States Cardiac Marker Revenue Market Share by Application (2015-2020)
6.5.3 United States Cardiac Marker Price by Application (2015-2020)
6.6 United States Cardiac Marker Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Cardiac Marker Sales Forecast by Application (2021-2026)
6.6.2 United States Cardiac Marker Revenue Forecast by Application (2021-2026)
6.6.3 United States Cardiac Marker Price Forecast by Application (2021-2026)
7 North America
7.1 North America Cardiac Marker Market Size YoY Growth 2015-2026
7.2 North America Cardiac Marker Market Facts & Figures by Country
7.2.1 North America Cardiac Marker Sales by Country (2015-2020)
7.2.2 North America Cardiac Marker Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Cardiac Marker Market Size YoY Growth 2015-2026
8.2 Europe Cardiac Marker Market Facts & Figures by Country
8.2.1 Europe Cardiac Marker Sales by Country
8.2.2 Europe Cardiac Marker Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Cardiac Marker Market Size YoY Growth 2015-2026
9.2 Asia Pacific Cardiac Marker Market Facts & Figures by Country
9.2.1 Asia Pacific Cardiac Marker Sales by Region (2015-2020)
9.2.2 Asia Pacific Cardiac Marker Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Cardiac Marker Market Size YoY Growth 2015-2026
10.2 Latin America Cardiac Marker Market Facts & Figures by Country
10.2.1 Latin America Cardiac Marker Sales by Country
10.2.2 Latin America Cardiac Marker Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Cardiac Marker Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Cardiac Marker Market Facts & Figures by Country
11.2.1 Middle East and Africa Cardiac Marker Sales by Country
11.2.2 Middle East and Africa Cardiac Marker Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 HyTest
12.1.1 HyTest Corporation Information
12.1.2 HyTest Description and Business Overview
12.1.3 HyTest Sales, Revenue and Gross Margin (2015-2020)
12.1.4 HyTest Cardiac Marker Products Offered
12.1.5 HyTest Recent Development
12.2 Abbott
12.2.1 Abbott Corporation Information
12.2.2 Abbott Description and Business Overview
12.2.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbott Cardiac Marker Products Offered
12.2.5 Abbott Recent Development
12.3 Roche Diagnostics
12.3.1 Roche Diagnostics Corporation Information
12.3.2 Roche Diagnostics Description and Business Overview
12.3.3 Roche Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Diagnostics Cardiac Marker Products Offered
12.3.5 Roche Diagnostics Recent Development
12.4 BG Medicine
12.4.1 BG Medicine Corporation Information
12.4.2 BG Medicine Description and Business Overview
12.4.3 BG Medicine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BG Medicine Cardiac Marker Products Offered
12.4.5 BG Medicine Recent Development
12.5 Biomerieux
12.5.1 Biomerieux Corporation Information
12.5.2 Biomerieux Description and Business Overview
12.5.3 Biomerieux Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Biomerieux Cardiac Marker Products Offered
12.5.5 Biomerieux Recent Development
12.6 Critical Diagnostics
12.6.1 Critical Diagnostics Corporation Information
12.6.2 Critical Diagnostics Description and Business Overview
12.6.3 Critical Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Critical Diagnostics Cardiac Marker Products Offered
12.6.5 Critical Diagnostics Recent Development
12.7 DiaDexus
12.7.1 DiaDexus Corporation Information
12.7.2 DiaDexus Description and Business Overview
12.7.3 DiaDexus Sales, Revenue and Gross Margin (2015-2020)
12.7.4 DiaDexus Cardiac Marker Products Offered
12.7.5 DiaDexus Recent Development
12.8 Response Biomedical
12.8.1 Response Biomedical Corporation Information
12.8.2 Response Biomedical Description and Business Overview
12.8.3 Response Biomedical Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Response Biomedical Cardiac Marker Products Offered
12.8.5 Response Biomedical Recent Development
12.9 Siemens Healthcare
12.9.1 Siemens Healthcare Corporation Information
12.9.2 Siemens Healthcare Description and Business Overview
12.9.3 Siemens Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Siemens Healthcare Cardiac Marker Products Offered
12.9.5 Siemens Healthcare Recent Development
12.10 Singulex
12.10.1 Singulex Corporation Information
12.10.2 Singulex Description and Business Overview
12.10.3 Singulex Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Singulex Cardiac Marker Products Offered
12.10.5 Singulex Recent Development
12.11 HyTest
12.11.1 HyTest Corporation Information
12.11.2 HyTest Description and Business Overview
12.11.3 HyTest Sales, Revenue and Gross Margin (2015-2020)
12.11.4 HyTest Cardiac Marker Products Offered
12.11.5 HyTest Recent Development
12.12 Trinity Biotech
12.12.1 Trinity Biotech Corporation Information
12.12.2 Trinity Biotech Description and Business Overview
12.12.3 Trinity Biotech Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Trinity Biotech Products Offered
12.12.5 Trinity Biotech Recent Development
12.13 Sunfory
12.13.1 Sunfory Corporation Information
12.13.2 Sunfory Description and Business Overview
12.13.3 Sunfory Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Sunfory Products Offered
12.13.5 Sunfory Recent Development
12.14 Lee BioSolutions
12.14.1 Lee BioSolutions Corporation Information
12.14.2 Lee BioSolutions Description and Business Overview
12.14.3 Lee BioSolutions Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Lee BioSolutions Products Offered
12.14.5 Lee BioSolutions Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Cardiac Marker Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cardiac Marker Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Cardiac Marker Market Segments
Table 2. Ranking of Global Top Cardiac Marker Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cardiac Marker Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Creatine kinase (CK) MB
Table 5. Major Manufacturers of Troponin (cTnI and cTnT)
Table 6. Major Manufacturers of BNP & NT-proBNP
Table 7. Major Manufacturers of Myogloblin
Table 8. Major Manufacturers of Others (hs-CRP, D-Dimer, etc.)
Table 9. Global Cardiac Marker Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 10. Global Cardiac Marker Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 11. Global Cardiac Marker Sales by Regions 2015-2020 (K Doses)
Table 12. Global Cardiac Marker Sales Market Share by Regions (2015-2020)
Table 13. Global Cardiac Marker Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Cardiac Marker Sales Forecast by Region (2021-2026) (K Doses)
Table 15. Global Cardiac Marker Sales by Manufacturers (2015-2020) (K Doses)
Table 16. Global Cardiac Marker Sales Share by Manufacturers (2015-2020)
Table 17. Global Cardiac Marker Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Cardiac Marker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Marker as of 2019)
Table 19. Cardiac Marker Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Cardiac Marker Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Cardiac Marker Price (2015-2020) (USD/Dose)
Table 22. Cardiac Marker Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Cardiac Marker Product Type
Table 24. Date of International Manufacturers Enter into Cardiac Marker Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Cardiac Marker Sales by Type (2015-2020) (K Doses)
Table 27. Global Cardiac Marker Sales Share by Type (2015-2020)
Table 28. Global Cardiac Marker Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Cardiac Marker Revenue Share by Type (2015-2020)
Table 30. Cardiac Marker Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 31. Global Cardiac Marker Sales Share by Type (2021-2026)
Table 32. Global Cardiac Marker Sales by Application (2015-2020) (K Doses)
Table 33. Global Cardiac Marker Sales Share by Application (2015-2020)
Table 34. Global Cardiac Marker Sales Share by Application (2021-2026)
Table 35. Global Cardiac Marker Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Cardiac Marker Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Cardiac Marker Revenue Market Share Forecast by Application (2021-2026)
Table 38. United States Cardiac Marker Sales (K Doses) of Key Companies (2015-2020)
Table 39. United States Cardiac Marker Sales Share by Company (2015-2020)
Table 40. United States Cardiac Marker Revenue (US$ Million) by Company (2015-2020)
Table 41. United States Cardiac Marker Sales (K Doses) by Type (2015-2020)
Table 42. United States Cardiac Marker Sales Share by Type (2015-2020)
Table 43. United States Cardiac Marker Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. United States Cardiac Marker Price (K Doses) by Type (2015-2020)
Table 45. United States Cardiac Marker Sales (K Doses) by Type (2021-2026)
Table 46. United States Cardiac Marker Sales Share by Type (2021-2026)
Table 47. United States Cardiac Marker Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. United States Cardiac Marker Revenue Share by Type (2021-2026)
Table 49. United States Cardiac Marker Price (K Doses) by Type (2021-2026)
Table 50. United States Cardiac Marker Sales (K Doses) by Application (2015-2020)
Table 51. United States Cardiac Marker Sales Share by Application (2015-2020)
Table 52. United States Cardiac Marker Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. United States Cardiac Marker Sales (K Doses) by Application (2021-2026)
Table 54. United States Cardiac Marker Sales Share by Application (2021-2026)
Table 55. United States Cardiac Marker Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. United States Cardiac Marker Revenue Share by Application (2021-2026)
Table 57. North America Cardiac Marker Sales by Country (2015-2020) (K Doses)
Table 58. North America Cardiac Marker Sales Market Share by Country (2015-2020)
Table 59. North America Cardiac Marker Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Cardiac Marker Revenue Market Share by Country (2015-2020)
Table 61. Europe Cardiac Marker Sales by Country (2015-2020) (K Doses)
Table 62. Europe Cardiac Marker Sales Market Share by Country (2015-2020)
Table 63. Europe Cardiac Marker Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Cardiac Marker Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Cardiac Marker Sales by Region (2015-2020) (K Doses)
Table 66. Asia Pacific Cardiac Marker Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Cardiac Marker Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Cardiac Marker Revenue Market Share by Region (2015-2020)
Table 69. Latin America Cardiac Marker Sales by Country (2015-2020) (K Doses)
Table 70. Latin America Cardiac Marker Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Cardiac Marker Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Cardiac Marker Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Cardiac Marker Sales by Country (2015-2020) (K Doses)
Table 74. Middle East and Africa Cardiac Marker Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Cardiac Marker Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Cardiac Marker Revenue Market Share by Country (2015-2020)
Table 77. HyTest Corporation Information
Table 78. HyTest Description and Business Overview
Table 79. HyTest Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 80. HyTest Cardiac Marker Product
Table 81. HyTest Recent Development
Table 82. Abbott Corporation Information
Table 83. Abbott Description and Business Overview
Table 84. Abbott Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 85. Abbott Product
Table 86. Abbott Recent Development
Table 87. Roche Diagnostics Corporation Information
Table 88. Roche Diagnostics Description and Business Overview
Table 89. Roche Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 90. Roche Diagnostics Product
Table 91. Roche Diagnostics Recent Development
Table 92. BG Medicine Corporation Information
Table 93. BG Medicine Description and Business Overview
Table 94. BG Medicine Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 95. BG Medicine Product
Table 96. BG Medicine Recent Development
Table 97. Biomerieux Corporation Information
Table 98. Biomerieux Description and Business Overview
Table 99. Biomerieux Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 100. Biomerieux Product
Table 101. Biomerieux Recent Development
Table 102. Critical Diagnostics Corporation Information
Table 103. Critical Diagnostics Description and Business Overview
Table 104. Critical Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 105. Critical Diagnostics Product
Table 106. Critical Diagnostics Recent Development
Table 107. DiaDexus Corporation Information
Table 108. DiaDexus Description and Business Overview
Table 109. DiaDexus Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 110. DiaDexus Product
Table 111. DiaDexus Recent Development
Table 112. Response Biomedical Corporation Information
Table 113. Response Biomedical Description and Business Overview
Table 114. Response Biomedical Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 115. Response Biomedical Product
Table 116. Response Biomedical Recent Development
Table 117. Siemens Healthcare Corporation Information
Table 118. Siemens Healthcare Description and Business Overview
Table 119. Siemens Healthcare Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 120. Siemens Healthcare Product
Table 121. Siemens Healthcare Recent Development
Table 122. Singulex Corporation Information
Table 123. Singulex Description and Business Overview
Table 124. Singulex Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 125. Singulex Product
Table 126. Singulex Recent Development
Table 127. Thermo Scientific Corporation Information
Table 128. Thermo Scientific Description and Business Overview
Table 129. Thermo Scientific Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 130. Thermo Scientific Product
Table 131. Thermo Scientific Recent Development
Table 132. Trinity Biotech Corporation Information
Table 133. Trinity Biotech Description and Business Overview
Table 134. Trinity Biotech Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 135. Trinity Biotech Product
Table 136. Trinity Biotech Recent Development
Table 137. Sunfory Corporation Information
Table 138. Sunfory Description and Business Overview
Table 139. Sunfory Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 140. Sunfory Product
Table 141. Sunfory Recent Development
Table 142. Lee BioSolutions Corporation Information
Table 143. Lee BioSolutions Description and Business Overview
Table 144. Lee BioSolutions Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 145. Lee BioSolutions Product
Table 146. Lee BioSolutions Recent Development
Table 147. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 148. Key Challenges
Table 149. Market Risks
Table 150. Main Points Interviewed from Key Cardiac Marker Players
Table 151. Cardiac Marker Customers List
Table 152. Cardiac Marker Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Cardiac Marker Product Picture
Figure 2. Global Cardiac Marker Sales Market Share by Type in 2020 & 2026
Figure 3. Creatine kinase (CK) MB Product Picture
Figure 4. Troponin (cTnI and cTnT) Product Picture
Figure 5. BNP & NT-proBNP Product Picture
Figure 6. Myogloblin Product Picture
Figure 7. Others (hs-CRP, D-Dimer, etc.) Product Picture
Figure 8. Global Cardiac Marker Sales Market Share by Application in 2020 & 2026
Figure 9. Myocardial Infarction
Figure 10. Congestive Heart Failure
Figure 11. Acute Coronary Syndrome
Figure 12. Atherosclerosis
Figure 13. Others
Figure 14. Cardiac Marker Report Years Considered
Figure 15. Global Cardiac Marker Market Size 2015-2026 (US$ Million)
Figure 16. Global Cardiac Marker Sales 2015-2026 (K Doses)
Figure 17. Global Cardiac Marker Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Cardiac Marker Sales Market Share by Region (2015-2020)
Figure 19. Global Cardiac Marker Sales Market Share by Region in 2019
Figure 20. Global Cardiac Marker Revenue Market Share by Region (2015-2020)
Figure 21. Global Cardiac Marker Revenue Market Share by Region in 2019
Figure 22. Global Cardiac Marker Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Cardiac Marker Revenue in 2019
Figure 24. Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Cardiac Marker Sales Market Share by Type (2015-2020)
Figure 26. Global Cardiac Marker Sales Market Share by Type in 2019
Figure 27. Global Cardiac Marker Revenue Market Share by Type (2015-2020)
Figure 28. Global Cardiac Marker Revenue Market Share by Type in 2019
Figure 29. Global Cardiac Marker Market Share by Price Range (2015-2020)
Figure 30. Global Cardiac Marker Sales Market Share by Application (2015-2020)
Figure 31. Global Cardiac Marker Sales Market Share by Application in 2019
Figure 32. Global Cardiac Marker Revenue Market Share by Application (2015-2020)
Figure 33. Global Cardiac Marker Revenue Market Share by Application in 2019
Figure 34. United States Cardiac Marker Sales Growth Rate 2015-2026 (K Doses)
Figure 35. United States Cardiac Marker Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. United States Cardiac Marker Market Share in Global Market 2015-2026
Figure 37. United States 5 and 10 Largest Cardiac Marker Players Market Share by Revenue in Cardiac Marker in 2019
Figure 38. United States Cardiac Marker Revenue Share by Type (2015-2020)
Figure 39. United States Cardiac Marker Revenue Growth Rate by Type in 2015 & 2019
Figure 40. United States Cardiac Marker Revenue Share by Application (2015-2020)
Figure 41. United States Cardiac Marker Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 43. North America Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Cardiac Marker Sales Market Share by Country in 2019
Figure 45. North America Cardiac Marker Revenue Market Share by Country in 2019
Figure 46. U.S. Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.S. Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Canada Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 51. Europe Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Cardiac Marker Sales Market Share by Country in 2019
Figure 53. Europe Cardiac Marker Revenue Market Share by Country in 2019
Figure 54. Germany Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 55. Germany Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 57. France Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 59. U.K. Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Italy Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Russia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 65. Asia Pacific Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Cardiac Marker Sales Market Share by Region in 2019
Figure 67. Asia Pacific Cardiac Marker Revenue Market Share by Region in 2019
Figure 68. China Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 69. China Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Japan Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 73. South Korea Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 75. India Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Australia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Taiwan Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Indonesia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 83. Thailand Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 85. Malaysia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Philippines Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Vietnam Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Latin America Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 91. Latin America Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Cardiac Marker Sales Market Share by Country in 2019
Figure 93. Latin America Cardiac Marker Revenue Market Share by Country in 2019
Figure 94. Mexico Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 95. Mexico Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 97. Brazil Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Argentina Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Middle East and Africa Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 101. Middle East and Africa Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Cardiac Marker Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Cardiac Marker Revenue Market Share by Country in 2019
Figure 104. Turkey Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 105. Turkey Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 107. Saudi Arabia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 109. U.A.E Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Porter's Five Forces Analysis
Figure 111. Cardiac Marker Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
  • Global Decongestant Market Research Report 2020
    Published: 30-Oct-2020        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Decongestant market is segmented into - Tablets - Capsules - Nasal Sprays Segment by Appl......
  • Global Medical Foods for Inborn Errors of Metabolism Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Medical Foods for Inborn Errors of Metabolism market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Foods for Inborn Errors of Metabolism business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growt......
  • Global OX40 Receptor Agonist Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the OX40 Receptor Agonist market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in OX40 Receptor Agonist business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of OX40 Receptor Agonist market ......
  • Global NF-KB Inhibitors Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the NF-KB Inhibitors market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in NF-KB Inhibitors business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of NF-KB Inhibitors market by product type......
  • Global and United States Diabetes Treatment Drugs Market Growth (Status and Outlook) 2020-2025
    Published: 30-Oct-2020        Price: US 3960 Onwards        Pages: 103
    This study researches the Diabetes Treatment Drugs market overview in global and United States market. For the global market, this report focuses on the market size of Diabetes Treatment Drugs in global, regional and country-level market, by regions (countries), by Type, and by Application, for the period 2015-2025. It also includes the Diabetes Treatment Drugs provides details and data information by players for the period 2015-2020. For United States market, the r......
  • Global Diabetes Treatment Drugs Market Growth (Status and Outlook) 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 131
    According to this study, over the next five years the Diabetes Treatment Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Diabetes Treatment Drugs business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Treatment Drugs market by ......
  • Global Knee Hyaluronic Acid Injection Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Knee Hyaluronic Acid Injection market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Knee Hyaluronic Acid Injection business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Knee Hyalur......
  • Global Medical Nitroglycerin Spray Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Medical Nitroglycerin Spray market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Nitroglycerin Spray business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Nitroglyc......
  • Global Ertapenem API Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Ertapenem API market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Ertapenem API business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem API market by product type, applica......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs